Overview

Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis

Status:
Terminated
Trial end date:
2017-12-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of ceftaroline for the treatment of Late Onset Sepsis in neonates and young infants aged 7 to <60 days
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Pfizer
Collaborator:
PRA Health Sciences
Treatments:
Ampicillin
Ceftaroline fosamil
Cephalosporins